Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Efficacy of Immune Checkpoint Inhibitors for In-Transit MelanomaJ Immunother Cancer 2020 May 01;8(1)5, E Nan Tie, J Lai-Kwon, MA Rtshiladze, L Na, J Bozzi, T Read, V Atkinson, G Au-Yeung, G Long, GA McArthur, S Sandhu, R Saw, E Walpole, A Menzies, M Smithers, DE Gyorki
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.